 |
FDA Approval Activities for this Drug
Spectracef (Cefditoren Pivoxil) Tablets, 200 mg, TAP Pharmaceutical Products NDA 21-222/S1 8/21/02 8/26/02 8/22/02
Spectracef (Cefditoren Pivoxil) Tablets, 200 mg TAP Pharmaceutical Products NDA 21-222 8/29/01 11/5/01 11/5/01 12/7/01
Spectracef Indications: Treatment of acute exacerbation of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections. Spectracef (Cefditoren Pivoxil) Tablets, Purdue Pharmaceutical
For the most up-to-date approval information, please locate this API using the drug index.
|